Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Type of study
Language
Publication year range
1.
Microbes Infect ; 18(3): 199-210, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26687036

ABSTRACT

Toxoplasma gondii is an obligate intracellular parasite that infects all nucleated cell types in diverse warm-blooded organisms. Many of the surface antigens and effector molecules secreted by the parasite during invasion and intracellular growth are modified by glycans. Glycosylated proteins in the nucleus and cytoplasm have also been reported. Despite their prevalence, the complete inventory and biological significance of glycosylated proteins in Toxoplasma remain unknown. In this study, we aimed to globally profile parasite glycoproteins using a bioorthogonal chemical reporter strategy. This strategy involves the metabolic incorporation of unnatural functional groups (i.e., "chemical reporters") into Toxoplasma glycans, followed by covalent labeling with visual probes or affinity tags. The two-step approach enables the visualization and identification of newly biosynthesized glycoconjugates in the parasite. Using a buffer that mimics intracellular conditions, extracellular Toxoplasma tachyzoites were found to metabolize and incorporate unnatural sugars (equipped with bioorthogonal functional groups) into diverse proteins. Covalent chemistries were used to visualize and retrieve these labeled structures. Subsequent mass spectrometry analysis revealed 89 unique proteins. This survey identified novel proteins as well as previously characterized proteins from lectin affinity analyses.


Subject(s)
Carbohydrate Metabolism , Glycoproteins/analysis , Protozoan Proteins/analysis , Toxoplasma/metabolism , Staining and Labeling
2.
Cell Host Microbe ; 14(1): 26-37, 2013 Jul 17.
Article in English | MEDLINE | ID: mdl-23870311

ABSTRACT

Host inflammation alters the availability of nutrients such as iron to limit microbial growth. However, Salmonella enterica serovar Typhimurium thrives in the inflamed gut by scavenging for iron with siderophores. By administering Escherichia coli strain Nissle 1917, which assimilates iron by similar mechanisms, we show that this nonpathogenic bacterium can outcompete and reduce S. Typhimurium colonization in mouse models of acute colitis and chronic persistent infection. This probiotic activity depends on E. coli Nissle iron acquisition, given that mutants deficient in iron uptake colonize the intestine but do not reduce S. Typhimurium colonization. Additionally, the ability of E. coli Nissle to overcome iron restriction by the host protein lipocalin 2, which counteracts some siderophores, is essential, given that S. Typhimurium is unaffected by E. coli Nissle in lipocalin 2-deficient mice. Thus, iron availability impacts S. Typhimurium growth, and E. coli Nissle reduces S. Typhimurium intestinal colonization by competing for this limiting nutrient.


Subject(s)
Colitis/drug therapy , Escherichia coli/metabolism , Intestines/microbiology , Iron/metabolism , Probiotics/therapeutic use , Salmonella Infections/microbiology , Salmonella typhimurium/growth & development , Salmonella typhimurium/metabolism , Animals , Colitis/metabolism , Colitis/microbiology , Female , Humans , Intestinal Mucosa/metabolism , Mice , Mice, Inbred C57BL , Probiotics/metabolism , Salmonella Infections/drug therapy , Salmonella Infections/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL